Researchers elucidated the shared immune tolerance mechanisms in cancer and pregnancy, focusing on the role of an immune checkpoint protein as an onco-fetal immune tolerance checkpoint.
Better Response, Survival in Head and Neck Cancer With Dual Pre-Op Immunotherapy
Nivolumab plus ipilimumab or relatlimab nearly doubled response rates compared to nivolumab alone in head and neck cancer. Patients with major pathologic responses had better